{"nct_id":"NCT01120457","title":"First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers","status":"COMPLETED","status_verified_date":"2015-01","start_date":"2010-08","start_date_type":null,"primary_completion_date":"2014-11","primary_completion_date_type":"ACTUAL","completion_date":"2014-11","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BMY"]}